Tag Archives: healthcare

The Cancer Death-Panel App

Annie Cavanagh. Wellcome Images

In an article for the New York Post, Robert Goldberg, vice president of the Center for Medicine in the Public Interest, wrote about an app that will use an algorithm like those health plans apply to limit access to innovative treatments: “At ASCO’s national conference, Dr. Lee Newcomer, United Healthcare’s medical director, said the ‘motives [of insurers] are viewed with suspicion when it comes to deciding whether a treatment is cost-effective. So having ASCO play Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

AIR 340B New Report: Contract Pharmacy Growth in 340B

AIR 340B

Today, the Alliance for Integrity and Reform of 340B (AIR 340B) released a white paper – The Impact of Growth in 340B Contract Pharmacy Arrangements – showingthat rapid contract pharmacy growth in the 340B program may not directly benefit the vulnerable patients for whom the program is intended. The paper highlights the growth of thousands of for-profit retail pharmacies – many of which are located in wealthier areas of the country. As of January 2014, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Exchange Plans are Helping Patients, But Challenges Remain

Session

After describing many of the benefits the Exchanges have brought to patients—including access to both coverage and federal subsidies—the moderator for the 2014 BIO International Convention breakout session, Impact of Exchanges for Patients, tasked panelists representing a diverse group of stakeholders to describe the challenges that remain for patients enrolled in Exchange plans. These challenges fell into four main categories, including: formulary depth, patient out-of-pocket costs, transparency, and provider networks. In terms of formulary depth, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Making the Case for Personalized Medicine

Personalized-Medicine

Personalized medicine is the customization of healthcare. Already, a suite of molecular approaches is being used to tailor certain medical decisions, practice and products to the individual patient. For example, melanoma, leukemia and metastatic lung, breast and brain cancers can be routinely “molecularly diagnosed” and treated with medicines that target the specific genetic mutations. These represent a remarkable improvement over trial-and-error medicine. Other diagnostic tests use the patient’s DNA sequence to determine drug-metabolizing capabilities. This Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

NIH, Patients and Industry Ramp Up to AMP-lify Innovation

Kay Holcomb

Speakers at Wednesday’s BIO 2014 Super Session – AMP-lifying Innovation: NIH, Patient Organizations & Leading Biopharma Firms Mobilize to Tackle Tough Diseases – discussed the new Accelerating Medicines Partnership (AMP) program, which is aimed at transforming the current model for developing new treatments by jointly identifying and validating promising biological targets of disease. AMP is a new venture among the NIH, several non-profit organizations and 10 biopharmaceutical companies focused on Alzheimer’s disease; type 2 diabetes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,